FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2148978886> ?p ?o ?g. }

• W2148978886 endingPage "3765" @default.
• W2148978886 startingPage "3759" @default.
• W2148978886 abstract "Cisplatin concomitantly administered with radiotherapy is increasingly used in locally advanced head and neck squamous cell carcinoma. We aimed to compare the incidence of hearing loss between patients treated with intra-arterial high-dose cisplatin chemoradiation with sodium thiosulfate (CRT-IA) and intravenous high-dose cisplatin chemoradiation without sodium thiosulfate (CRT-IV).We conducted a prospective analysis of hearing thresholds at low and (ultra-) high frequencies obtained before, during, and after treatment in 158 patients. Patients were randomly assigned for either CRT-IA (150 mg/m(2), four courses) with sodium thiosulfate cisplatin neutralization or CRT-IV (100 mg/m(2), three courses) without rescue. All patients received concomitant radiation therapy (RT; 70 Gy).CRT-IA resulted in approximately 10% less hearing loss at frequencies vital for speech perception, compared with CRT-IV (P < .001). In CRT-IA, fewer ears qualified for hearing aids (36% v 49%; P = .03). However, in both treatment arms, the incidence expressed in National Cancer Institute Common Terminology Criteria of Adverse Events (version 3) did not deviate (P > .14). Age, cumulative cisplatin dose, cumulative RT dose, and the considered frequency area determine the degree of hearing loss (P < .001). Cisplatin induced increasing hearing loss of 24% to 60% with increasing frequencies. RT induced hearing loss at speech frequencies of 9% to 12%.Depending on the criteria used to assess hearing loss due to treatment, differences in ototoxicity between CRT-IA and CRT-IV were found in favor of CRT-IA. It is desirable to specify hearing loss criteria toward frequencies vital for speech perception, and to refine grading scales to reveal subtle and clinically relevant dissimilarities in ototoxicity between different treatment protocols." @default.
• W2148978886 created "2016-06-24" @default.
• W2148978886 creator A5036057764 @default.
• W2148978886 creator A5037999969 @default.
• W2148978886 creator A5045353714 @default.
• W2148978886 creator A5053348185 @default.
• W2148978886 creator A5063155328 @default.
• W2148978886 creator A5064661665 @default.
• W2148978886 creator A5074570418 @default.
• W2148978886 creator A5082601500 @default.
• W2148978886 date "2007-08-20" @default.
• W2148978886 modified "2023-10-14" @default.
• W2148978886 title "Ototoxicity in a Randomized Phase III Trial of Intra-Arterial Compared With Intravenous Cisplatin Chemoradiation in Patients With Locally Advanced Head and Neck Cancer" @default.
• W2148978886 cites W1967277169 @default.
• W2148978886 cites W1973365939 @default.
• W2148978886 cites W1976360578 @default.
• W2148978886 cites W1977878414 @default.
• W2148978886 cites W1979164573 @default.
• W2148978886 cites W1979602376 @default.
• W2148978886 cites W1981704089 @default.
• W2148978886 cites W1988317326 @default.
• W2148978886 cites W2007557191 @default.
• W2148978886 cites W2012645265 @default.
• W2148978886 cites W2013773453 @default.
• W2148978886 cites W2014432727 @default.
• W2148978886 cites W2015897095 @default.
• W2148978886 cites W2019202778 @default.
• W2148978886 cites W2028297759 @default.
• W2148978886 cites W2033952121 @default.
• W2148978886 cites W2034502050 @default.
• W2148978886 cites W2036005555 @default.
• W2148978886 cites W2041197896 @default.
• W2148978886 cites W2041582395 @default.
• W2148978886 cites W2059222870 @default.
• W2148978886 cites W2060933374 @default.
• W2148978886 cites W2063306613 @default.
• W2148978886 cites W2069267613 @default.
• W2148978886 cites W2081477551 @default.
• W2148978886 cites W2085309922 @default.
• W2148978886 cites W2095930367 @default.
• W2148978886 cites W2101325978 @default.
• W2148978886 cites W2117677606 @default.
• W2148978886 cites W2120068217 @default.
• W2148978886 cites W2141139786 @default.
• W2148978886 cites W2144699072 @default.
• W2148978886 cites W2145078756 @default.
• W2148978886 cites W2148513193 @default.
• W2148978886 cites W2151956556 @default.
• W2148978886 cites W2152609192 @default.
• W2148978886 cites W2155741042 @default.
• W2148978886 cites W2163666497 @default.
• W2148978886 cites W2289214850 @default.
• W2148978886 cites W2289802802 @default.
• W2148978886 cites W2413399178 @default.
• W2148978886 doi "https://doi.org/10.1200/jco.2006.08.9540" @default.
• W2148978886 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17704425" @default.
• W2148978886 hasPublicationYear "2007" @default.
• W2148978886 type Work @default.
• W2148978886 sameAs 2148978886 @default.
• W2148978886 citedByCount "55" @default.
• W2148978886 countsByYear W21489788862012 @default.
• W2148978886 countsByYear W21489788862013 @default.
• W2148978886 countsByYear W21489788862014 @default.
• W2148978886 countsByYear W21489788862015 @default.
• W2148978886 countsByYear W21489788862016 @default.
• W2148978886 countsByYear W21489788862017 @default.
• W2148978886 countsByYear W21489788862018 @default.
• W2148978886 countsByYear W21489788862019 @default.
• W2148978886 countsByYear W21489788862020 @default.
• W2148978886 countsByYear W21489788862021 @default.
• W2148978886 countsByYear W21489788862022 @default.
• W2148978886 crossrefType "journal-article" @default.
• W2148978886 hasAuthorship W2148978886A5036057764 @default.
• W2148978886 hasAuthorship W2148978886A5037999969 @default.
• W2148978886 hasAuthorship W2148978886A5045353714 @default.
• W2148978886 hasAuthorship W2148978886A5053348185 @default.
• W2148978886 hasAuthorship W2148978886A5063155328 @default.
• W2148978886 hasAuthorship W2148978886A5064661665 @default.
• W2148978886 hasAuthorship W2148978886A5074570418 @default.
• W2148978886 hasAuthorship W2148978886A5082601500 @default.
• W2148978886 hasBestOaLocation W21489788861 @default.
• W2148978886 hasConcept C126322002 @default.
• W2148978886 hasConcept C126894567 @default.
• W2148978886 hasConcept C179104552 @default.
• W2148978886 hasConcept C185592680 @default.
• W2148978886 hasConcept C197934379 @default.
• W2148978886 hasConcept C2776530083 @default.
• W2148978886 hasConcept C2776694085 @default.
• W2148978886 hasConcept C2777793932 @default.
• W2148978886 hasConcept C2778239845 @default.
• W2148978886 hasConcept C2778534666 @default.
• W2148978886 hasConcept C2779525547 @default.
• W2148978886 hasConcept C2780493683 @default.
• W2148978886 hasConcept C509974204 @default.
• W2148978886 hasConcept C548259974 @default.
• W2148978886 hasConcept C71924100 @default.
• W2148978886 hasConceptScore W2148978886C126322002 @default.
• W2148978886 hasConceptScore W2148978886C126894567 @default.

• next